Close Menu

NEW YORK  — Chronic disease laboratory company Salveo Diagnostics this week announced its acquisition of autoimmune-focused diagnostics firm ImmunArray and health engagement platform Nudge.

Financial and other terms of the deal were not released.

The firms said the merger will expand Salveo's testing abilities and improve communication between providers and patients while also allowing patients to access lab results on their smartphones.

All three companies are based in Richmond, Virginia. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.